ArticleBMC infectious diseases2025
Seroprevalence of dengue virus infection among febrile patients visiting healthcare facilities in the selected districts of Afar region, Northeast Ethiopia.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDengue fever (DF) is caused by dengue virus (DENV) and is primarily spread through bites of infected Aedes mosquitoes in tropical and subtropical regions, including Ethiopia. In the Afar region, DF is often misdiagnosed as malaria due to limited diagnostic capabilities. This study assessed the seroprevalence of DENV infection among febrile patients in healthcare facilities in the Afar region.
methodsA cross-sectional study was conducted from September 2022 to March 2023 in Amibara, Harunka and Awash Sebat city administration districts, involving febrile patients suspected of having malaria. Sociodemographic data, clinical features and blood samples were collected from participants after obtaining informed consent or assent. Following blood film examination for Plasmodium infection, sera were tested for anti-DENV IgM and IgG antibodies using enzyme-linked immunosorbent assay (ELISA). Data were entered into Epi Data 3.1 and analyzed with Stata/SE 14.2. A p-value < 0.05 was considered significant.
resultsA total of 411 febrile patients (55.5% female, aged 5-80 years, with a mean age of 27.3 ± 13.8 years) participated in the study. Among those tested for anti-DENV antibodies, 101/410 (24.6%) were positive for anti-DENV IgM, indicating an acute DENV infection, and 142/367 (38.7%) were positive for anti-DENV IgG, revealing previous exposure. Only 44/411 (10.7%) were positive for Plasmodium infection, while 18/410 (4.4%) were co-infected with malaria and acute DENV infection and 18/367 (4.9%) were positive for both malaria and previous exposure to DENV. Those diagnosed with malaria were nearly 2.5 times more likely to test positive for acute DENV infection than those without malaria (AOR = 2.37; 95% CI 1.14-4.92). The odds of positivity for previous exposure were about two times higher in females than in males (AOR = 2.24; 95% CI 1.32-3.26) and in government and private sector employees than in pastoralists and agro-pastoralists (AOR = 1.90; 95% CI 1.03-8.15), while patients aged 11-20 years had lower odds of previous exposure than those aged 5-10 years (AOR = 0.35; 95% CI 0.14-0.88). Experiencing muscle pain was associated with twice the odds of previous exposure (AOR = 1.90; 95% CI 1.04-3.49).
conclusionThe study reveals a high seroprevalence of DENV infection among febrile patients in the study area, highlighting the need for routine diagnosis and management of DF in this setting. Improving vector control, disease surveillance and public awareness would be crucial for combating DF and other mosquito-borne diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.